Form 4 for CL Colgate-Palmolive
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001225208-23-001250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-01 | CL | NORRINGTON LORRIE M | Dir | S - Sale+OE | $74.13 | -5,703 | 27.5K | -17% | -$422.8K |
| D | 2023-02-03 | 2023-02-01 | CL | NORRINGTON LORRIE M | Dir | M - OptEx | $71.65 | +5,703 | 33.2K | +21% | +$408.6K |
| D | 2023-02-03 | 2023-02-01 | CL | NORRINGTON LORRIE M | Dir | M - OptEx | $0.00 | -5,703 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | S | D | 5,703 | $74.13 | 27,500 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | M | A | 5,703 | $71.65 | 33,203 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-02-01 | M | D | 5,703 | $0.00 | 0 | D | $71.65 · — to 2023-05-15 | 5,703 Common Stock | (F3) Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date. |